Percutaneous coronary intervention with stenting is an appropriate alternative to surgical revascularization in the management of coronary artery disease. Despite new medications and techniques, in-stent restenosis still remains an unresolved problem. Brachytherapy and drug-eluting stents are current therapeutic options to reduce in-stent restenosis and decrease the probability of its occurrence, respectively. This article revisits the pathophysiology and current therapeutic modalities of in-stent restenosis.
Keywords: Angioplasty, transluminal, percutaneous coronary; brachytherapy; coronary restenosis/physiopathology/therapy; drug implants; stentsCopyright © 2025 Archives of the Turkish Society of Cardiology